| Application no. and date | 17712175.3 (espacenet) (Federated) (European Patent Register), 20170324 | | Patent/reg. no. and date | DK/EP 3240538, 20210929 | | Publication date | 20171108 | | Priority no. and date | EP 16162490, 20160325 | | EP pub. no. and date |
EP 3240538 20171108 | | Effective date | | | Applicant/owner | AB Science, 3, avenue George V
75008 Paris, FR | | Applicant ref. no. | V2111-066-DK | | Inventor | Moussy, Alain, 22bis passage Dauphine
75006 PARIS, FR,
MANSFIELD, Colin, 1 avenue Paul Santy
Bâtiment C
69130 Écully, FR,
KINET, Jean-Pierre, 62 Gleason Road
Lexington, Massachusetts 02420, FR | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 31/496 (2006.01) , A61P 25/28 (2006.01) | | Title | ANVENDELSE AF MASITINIB TIL BEHANDLING AF EN UNDERPOPULATION AF PATIENTER MED AMYOTROFISK LATERALSKLEROSE | | Int. application no. | EP2017057134 | | Int. publication no. | WO2017162884 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
